Levodopa for Dystonia in Children: A Case Series and Review of the Literature

Pediatr Neurol. 2024 Mar:152:16-19. doi: 10.1016/j.pediatrneurol.2023.12.012. Epub 2023 Dec 19.

Abstract

Background: Levodopa is used to treat hyperkinetic movements in children with dopa-responsive dystonia. However, levodopa may also be helpful in treating other forms of dystonia when used beyond a brief trial period.

Methods: We performed a retrospective review of all children referred to our institution for evaluation of generalized dystonia and subsequently treated with carbidopa-levodopa. Motor function was assessed using video recordings and examination notes, quantified with the Burke-Fahn-Marsden Dystonia Rating Scale.

Results: Long-term treatment with carbidopa-levodopa moderately improved motor function, whereas short-term use did not. Carbidopa-levodopa was well tolerated without untoward effects.

Conclusions: Dystonia is a significant cause of disability with limited effective treatment options. Published work is restricted but generally supports the findings of this review. A well-controlled study to examine the utility of carbidopa-levodopa treatment for dystonia is needed.

Keywords: Carbidopa-levodopa; Dopa-responsive dystonia; Dopamine; Dyskinetic cerebral palsy; Dystonia.

Publication types

  • Review

MeSH terms

  • Carbidopa / therapeutic use
  • Child
  • Dystonia* / diagnosis
  • Dystonic Disorders* / drug therapy
  • Humans
  • Levodopa / therapeutic use
  • Treatment Outcome

Substances

  • Levodopa
  • Carbidopa